ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

NCI selects nanotech centers for funding.

October 14, 2005

Federal Funding: IOM Report Praises DOD Breast Cancer Research Program

August 15, 1997

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985